The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.
This multi-center, observational registry will be used to evaluate the effectiveness of ProChondrix CR in patients who undergo treatment for an articular cartilage defect in the knee, ankle, foot or hip. This registry will be performed at up to 30 clinical sites across the United States. Patient follow-up will occur following an articular cartilage repair procedure in which the patient receives ProChondrix CR. During this follow-up period, each patient will be evaluated at least four (4) times at: 3, 6, 12 and 24 months after surgical intervention and will continue annually for as long as patients are willing to fill out questionnaires and outcomes assessments up to 10 years post operatively.
Study Type
OBSERVATIONAL
Enrollment
48
Patient reported outcomes will be collected on patients who have had a cartilage repair procedure using ProChondrix CR in the knee, hip, foot or ankle.
University of Southern Alabama
Mobile, Alabama, United States
Rocky Mountain Foot and Ankle Center
Wheat Ridge, Colorado, United States
CAO Research Foundation
Washington D.C., District of Columbia, United States
University of Kentucky Research Foundation
Lexington, Kentucky, United States
Long-Term Outcomes of ProChondrix CR
Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.
Time frame: 10 Years Post-Operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Beacon Orthopaedics & Sports Medicine
Cincinnati, Ohio, United States